Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas

Area of Science:

• Immunohistochemistry
• Lymphoid Neoplasms
• Cell Biology

Background:

• Dendritic reticulum cells (DRCs) are crucial components of lymphoid follicles.
• The expression of low-affinity nerve growth factor receptor (NGFR) on DRCs is not fully understood in various lymphoid conditions.
• Differentiating between reactive lymphoid changes and neoplastic processes can be challenging.

Purpose of the Study:

• To investigate the expression patterns of NGFR on DRCs in reactive lymphoid tissues and various non-Hodgkin's and Hodgkin's lymphomas.
• To assess the utility of NGFR immunoreactivity as a potential diagnostic marker in lymphoproliferative disorders.

Main Methods:

• Immunohistochemical analysis of frozen and paraffin-embedded lymphoid and splenic tissues.
• Utilized NGFR-specific antibody (NGFR5) and DRC-specific antibody (DRC-1).
• Examined tissues from reactive follicular hyperplasia, various subtypes of non-Hodgkin's lymphoma, chronic lymphocytic leukemia, marginal zone lymphoma, mantle cell lymphoma, and Hodgkin's disease.

Main Results:

• DRCs in reactive follicular hyperplasia uniformly expressed NGFR.
• Follicular non-Hodgkin's lymphomas showed uniform NGFR immunoreactivity on DRCs, similar to DRC-1 staining.
• Mantle cell lymphomas exhibited NGFR-reactive DRCs, suggesting diagnostic utility.
• Diffuse large cell, immunoblastic, small noncleaved cell lymphomas, chronic lymphocytic leukemia, and marginal zone lymphoma generally lacked significant tumor-associated NGFR-positive DRCs.

Conclusions:

• NGFR expression is retained on DRCs in follicular non-Hodgkin's lymphomas and mantle cell lymphomas.
• NGFR immunoreactivity can aid in the differential diagnosis of low-grade lymphoproliferative disorders.
• Nerve growth factor and NGFR may play a role in DRC function and matrix formation in normal and neoplastic lymphoid tissues.